Larimar Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Larimar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Larimar Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Larimar Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $128k | 28k | 4.55 |
2023-09-30 | $56k | 14k | 3.95 |
2023-06-30 | $90k | 29k | 3.13 |
2023-03-31 | $27k | 5.9k | 4.50 |
2022-12-31 | $297 | 72 | 4.13 |
2022-09-30 | $0 | 3.3k | 0.00 |
2022-06-30 | $0 | 601 | 0.00 |
2022-03-31 | $0 | 1.7k | 0.00 |
2021-12-31 | $0 | 1.1k | 0.00 |
2021-09-30 | $0 | 8 | 0.00 |
2021-06-30 | $0 | 8 | 0.00 |
2021-03-31 | $0 | 8 | 0.00 |
2020-12-31 | $6.0k | 299 | 20.07 |